SWAG enters the post-earnings period with a sharply different short-interest picture than just a week ago.
Stran & Company reported Q1 2026 results on May 12 — revenue of $31.2 million, up from $28.7 million a year earlier, and EPS of $0.04 versus a loss of $0.02 in Q1 2025. That profitability inflection arrived alongside a signal from management that buybacks may resume, and the company unveiled a new unit, Stran Digital Solutions, signalling a push into higher-margin digital services. The stock gave back 0.6% on May 12 despite the headline beat, finishing at $1.68 — still up 3.7% on the week.
The most striking shift is in short positioning. Estimated short interest collapsed 53% in a single session on May 12, falling to roughly 17,000 shares, or just 0.09% of the free float — the lowest reading in weeks and well below the 93,000-share peak seen on April 23. The reversal ran through the whole month: short interest is down 34% week-on-week and 64% over the past month. That is an aggressive unwind, not a gradual drift. The ORTEX short score has eased to 27.9, confirming the retreat in conviction from those who had been building positions.
The borrow market tells a slightly contrarian sub-story. Cost to borrow rose 36% over the week to 4.4% APR — its highest level since data began building in early April, when it was below 1%. A sevenfold increase in CTB over a month while short interest simultaneously collapses is an unusual combination. It points to a much smaller pool of borrowed shares that is now harder, not easier, to access. Borrow availability is very loose in absolute terms — the lending pool is far from stretched — but CTB signals that demand relative to available inventory has shifted.
Ownership is tightly concentrated at the top. Andrew Stranberg and Andrew Shape, the company's founders, together hold over 45% of shares, with Stranberg at 27.6% and Shape at 17.7%, both unchanged as of the most recent reporting period. Below that level, institutional interest is thin: Mink Brook Asset Management added roughly 197,000 shares through Q1, while Vanguard added 41,000. The holder count stands at just 24 institutional names, which underscores the thinly traded nature of the stock and explains why even small positioning changes register sharply in short interest data. The most recent insider activity on record is a 100,000-share sale by CEO Andrew Shape in August 2025 at $1.47 — below the current price — though that data is now more than eight months old.
Analyst coverage is stale and should be treated with caution. The only public rating on file is a Buy at a $4.50 target from EF Hutton, last reiterated in May 2023 — nearly three years ago. At a $1.68 close, the implied gap to that target is wide, but the data is too dated to carry weight. No current Street consensus is available.
What to watch next: whether the Q1 profitability print and the buyback signal attract fresh institutional holders into an ownership base that remains almost entirely founder-controlled, and whether the CTB drift higher continues even as the short base thins.
See the live data behind this article on ORTEX.
Open SWAG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
